Publications by authors named "Hazel Yetiskin"

Claim this Profile
V
Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months.
Seçil Yılmaz, Ahmet Eken, Zafer Sezer, Burcu Şen Bağcı, Serife Erdem, Hazel Yetiskin

Front Med (Lausanne)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants.
Busra Kaplan, Shaikh Terkis Islam Pavel, Muhammet Ali Uygut, Merve Tunc, Yesari Eroksuz, Hazel Yetiskin

Vaccines (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up.
Zafer Sezer, Shaikh Terkis Islam Pavel, Ahmet Inal, Hazel Yetiskin, Busra Kaplan

Vaccines (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants.
Tarlan Mamedov, Damla Yuksel, Irem Gurbuzaslan, Burcu Gulec, Gulshan Mammadova, Hazel Yetiskin

Front Plant Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants.
Tarlan Mamedov, Damla Yuksel, Irem Gurbuzaslan, Merve Ilgin, Burcu Gulec, Hazel Yetiskin

Front Plant Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials.
Aykut Ozdarendeli, Zafer Sezer, Shaikh Terkis Islam Pavel, Ahmet Inal, Hazel Yetiskin

Vaccine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.
Neslihan Pakize Taşlı, Zeynep Burçin Gönen, Oğuz Kaan Kırbaş, Nur Seda Gökdemir, Batuhan Turhan Bozkurt

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Inactivated Vaccine against SARS CoV-2.
Shaikh Terkis Islam Pavel, Hazel Yetiskin, Muhammet Ali Uygut, Ahmet Furkan Aslan, Günsu Aydın

Vaccines (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Plant as a Vaccine Candidate against COVID-19.
Tarlan Mamedov, Damla Yuksel, Merve Ilgın, Irem Gürbüzaslan, Burcu Gulec, Hazel Yetiskin

Vaccines (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice.
Tarlan Mamedov, Damla Yuksel, Merve Ilgın, Irem Gurbuzaslan, Burcu Gulec, Hazel Yetiskin

Viruses· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
Shaikh Terkis Islam Pavel, Hazel Yetiskin, Ahmet Kalkan, Aykut Ozdarendeli

PLoS Negl Trop Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey.
Shaikh Terkis Islam Pavel, Hazel Yetiskin, Gunsu Aydin, Can Holyavkin, Muhammet Ali Uygut

PLoS One· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis